IndraLab

Statements

USP26 inhibits osteoclastic differentiation bone myelomonocytes. 1 / 1

| 1

eidos

"Mechanistically , USP26 stabilizes beta-catenin to promote the osteogenic activity of mesenchymal cells ( MSCs ) and impairs the osteoclastic differentiation of bone myelomonocytes ( BMMs ) by stabilizing inhibitors of NF-kappaBalpha ( IkappaBalpha ) ."

35091692

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP26 inhibits osteoclastic differentiation bone myelomonocytes. 1 / 1

INDRA sources:

Databases

Reading